SO-AKI-TP: Association Between Renal Regional Oxygen Saturation Measured by Near-InfraRed Spectroscopy and Postoperative Renal Failure After Lung Transplantation Surgery: A Pilot Study

Sponsor
Assistance Publique Hopitaux De Marseille (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05836922
Collaborator
(none)
80
36

Study Details

Study Description

Brief Summary

Complications after lung transplantation are almost ubiquitous, among which postoperative acute renal failure may represent more than 50% of lung transplant patients and require extrarenal purification in 5 to 13% of cases.

Multiple factors are associated with postoperative acute renal failure. These factors can be classified into preoperative, intraoperative, and postoperative factors. While some postoperative complications are explained by donor and recipient factors, the literature suggests that certain intraoperative events represent modifiable or avoidable risk factors that could be targeted by therapeutic interventions to reduce the risk of postoperative acute renal failure. Some of these factors (intraoperative hemodynamic instability, significant bleeding or hypoxemia) can generate renal hypoxic aggression, alone or in combination. However, to date, there is no validated tool available at the patient's bedside during surgery to detect renal hypoxia or guide interventions to restore renal perfusion during surgery. Yet, as recent recommendations suggest, intraoperative renal protection is an important axis for improving the outcome of lung transplant patients, to the extent that the recommendations of Marczin et al. recommend the establishment of a renal prevention protocol for each patient. Without a tool to guide this plan intraoperatively, anesthesia teams can't establish a renal prevention protocol. This research aims to establish whether renal NIRS is a reliable tool for monitoring intraoperative renal hypoxic aggression predictive of postoperative renal failure.

Near-infrared spectroscopy (NIRS) is an optical technology that allows non-invasive measurement of tissue oxygen saturation. This technique is commonly used for intraoperative monitoring of cerebral perfusion in adults and children. Some studies have shown that regional renal oxygen saturation (renal rSO2) measured by NIRS during aortic-coronary bypass surgery under extracorporeal circulation (ECC) is correlated with renal venous oxygen saturation measured by catheterization. It is also associated with the risk of postoperative acute renal failure in patients undergoing cardiac surgery under ECC. However, there are no equivalent data in lung transplant patients, who frequently present with postoperative acute renal failure. In the available literature, no clear threshold of renal desaturation has been established. Because it is assumed that the depth of renal desaturation can be particularly deleterious, in addition to desaturation time, the investigator have chosen to retain in this project the integral of time and magnitude spent under a renal desaturation threshold, aggregated into a renal hypoxia index, during the intraoperative period.

The primary objective of this research is to demonstrate the usefulness of measuring the intraoperative renal hypoxia index in predicting the risk of early postoperative acute renal failure

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    80 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Association Between Renal Regional Oxygen Saturation Measured by Near-InfraRed Spectroscopy and Postoperative Renal Failure After Lung Transplantation Surgery: A Pilot Study
    Anticipated Study Start Date :
    Jul 1, 2023
    Anticipated Primary Completion Date :
    Jul 1, 2025
    Anticipated Study Completion Date :
    Jul 1, 2026

    Outcome Measures

    Primary Outcome Measures

    1. Relation between renal hypoxia index and AKI [5 days postoperative]

      Early postoperative acute kidney injury (AKI) is determined by a KDIGO stage ≥ 1 occurring between the end of the surgery and the 5th postoperative day (the KDIGO stage is defined by the variation of serum creatinine and urine output according to The Kidney Disease Improving Global Outcomes (KDIGO) Working Group). The renal hypoxia index is expressed in %·min. It will be tested for several critical saturation thresholds: 70%, 65%, 60%, 55%, 50%. The threshold of 65% is selected for the main analysis based on the work of Ortega-Loubon, and the other thresholds will be tested in a secondary analysis. For the main analysis, the interest of the index will be demonstrated by comparing the means of this index between the group that developed AKI and the group that did not. In the secondary analysis, the interest of the index will be demonstrated by studying the performance of the index for the occurrence of AKI, by estimating the ROC curve and the area under the ROC curve.

    Secondary Outcome Measures

    1. Relation between renal hypoxia index and renal replacment therapy [5 days postoperative]

      The use of renal replacement therapy during the 5 first postoperative days

    2. Relation between renal hypoxia index and primary graft dysfuncion [5 days postoperative]

      Primary graft dysfunction based on ISHLT 2016 stadification

    3. Relation between hypotension index and acute kidney injury [5 days postoperative]

      The hypotension index represent the time spent below 65mmHg of Mean Arterial Pressure (PAM) during the surgery is expressed in mmHg.min.Early postoperative acute kidney injury is determined by a KDIGO stage ≥ 1 occurring between the end of the surgery and the 5th postoperative day (the KDIGO stage is defined by the variation of serum creatinine and urine output according to The Kidney Disease Improving Global Outcomes (KDIGO) Working Group).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patient undergoing a lung transplant (mono or bi-transplantation)

    • Age >= 18 years

    • Affiliated to the French social security system

    Exclusion Criteria:
    • Renal anatomical abnormality likely to induce a misleading NIRS signal: single kidney, polycystic kidney disease.

    • Expression of opposition to participation in the research protocol.

    • Hyperbilurbinemia > 17mmol/l

    • Preoperative Extra Corporeal Membran Oxygenation (ECMO).

    • Preoperative mechanical ventilation

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Assistance Publique Hopitaux De Marseille

    Investigators

    • Study Director: François CREMIEUX, Assistance Publique Hopitaux De Marseille

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Assistance Publique Hopitaux De Marseille
    ClinicalTrials.gov Identifier:
    NCT05836922
    Other Study ID Numbers:
    • RCAPHM23_0007
    First Posted:
    May 1, 2023
    Last Update Posted:
    May 1, 2023
    Last Verified:
    Apr 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 1, 2023